Dosage and administration
• adults and children 12 years of age and over: 1 softgel (50 mg) at bedtime if needed, or as directed by a doctor
• adults and children 12 years of age and over: 1 softgel (50 mg) at bedtime if needed, or as directed by a doctor
Diphenhydramine HCl 50 mg
Nighttime sleep-aid
taking sedatives or tranquilizers
avoid alcoholic drinks
sleeplessness persists continuously for more than 2 weeks. Insomnia may be a symptom of serious underlying medical illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
edible dye-free ink*, gelatin, glycerin, polyethylene glycol, purified water, sorbitol sorbitan solution *may contain this ingredient
1-800-719-9260
VALUE SIZE 60 SOFTGELS
Compare to the active ingredient in Unisom® SleepGels®
SoftGels
Nighttime Sleep-Aid
DIPHENHYDRAMINE HCl 50 mg
Free of artificial dyes & preservatives
Non-habit forming
One softgel per dose
60 SOFTGELS
Actual Bottle Size on Top Panel
Actual Size


Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69842-439 | 69842-439-33 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | TC2D6JAD40 | ACTIB |
| GELATIN, UNSPECIFIED | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| WATER | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 343180d0-b7ba-4559-b580-42f6e412f984 | d5b063d6-a6b1-4e42-a278-61f65e7fa376 | 2020-10-26 | Warnings | d5b063d6-a6b1-4e42-a278-61f65e7fa376 |
Adverse event summaries are temporarily unavailable. Other product information remains available.